Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 70.02B | 69.23B | 65.45B | 58.76B | 52.15B | 49.91B |
Gross Profit | 10.75B | 10.68B | 10.04B | 10.17B | 9.63B | 5.66B |
EBITDA | 9.86B | 9.18B | 7.76B | 8.20B | 7.69B | 2.11B |
Net Income | 4.93B | 4.23B | 3.79B | 4.25B | 4.21B | -1.13B |
Balance Sheet | ||||||
Total Assets | 129.04B | 129.21B | 118.87B | 115.94B | 107.05B | 110.09B |
Cash, Cash Equivalents and Short-Term Investments | 12.70B | 19.18B | 18.83B | 18.55B | 16.20B | 16.36B |
Total Debt | 10.63B | 11.28B | 11.32B | 10.98B | 13.46B | 15.62B |
Total Liabilities | 105.89B | 109.52B | 101.14B | 102.96B | 97.56B | 103.64B |
Stockholders Equity | 23.06B | 19.61B | 17.70B | 12.95B | 9.47B | 6.45B |
Cash Flow | ||||||
Free Cash Flow | 2.48B | 3.93B | 3.35B | 3.92B | 2.79B | -7.18B |
Operating Cash Flow | 6.18B | 7.60B | 6.41B | 6.39B | 4.72B | -5.42B |
Investing Cash Flow | -5.42B | -6.72B | -4.13B | -3.07B | -2.66B | 4.21B |
Financing Cash Flow | -2.87B | -2.70B | -1.42B | -2.26B | -2.32B | 6.74B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | €138.67B | 28.05 | 23.80% | 1.70% | 5.12% | 59.43% | |
70 Outperform | €119.82B | 27.82 | 35.36% | 1.00% | 14.19% | 161.87% | |
68 Neutral | €48.69B | 71.24 | 14.51% | 1.60% | 11.16% | -50.57% | |
66 Neutral | €21.11B | 27.05 | 12.93% | 1.75% | 29.91% | -2.24% | |
63 Neutral | $10.64B | 16.04 | 5.48% | 2.12% | 2.73% | -23.95% |